|
G |
ACE |
angiotensin I converting enzyme |
|
ISO |
associated with colorectal cancer;mRNA:increased expression:liver (mouse) |
RGD |
PMID:20380732 |
RGD:25671446 |
NCBI chr 9:11,497,182...11,516,362
Ensembl chr 9:11,497,182...11,516,358
|
|
G |
BRAF |
B-Raf proto-oncogene, serine/threonine kinase |
severity |
ISO |
associated with skin melanoma;DNA:missense mutations:cds: associated with colorectal cancer;DNA:missense mutation:cds:p.V600E (human) associated with colorectal cancer;DNA:mutations:multiple associated with colorectal cancer;DNA:mutation:cds: associated with colorectal cancer;DNA:missense mutations:cds:pV599E,p.V600E (human) |
RGD |
PMID:22331825 PMID:23010994 PMID:26775732 PMID:27737491 PMID:28787433 |
RGD:11554843 RGD:14696791 RGD:15039394 RGD:18337264 RGD:18337265 |
NCBI chr16:8,222,909...8,318,179
Ensembl chr16:8,222,907...8,317,906
|
|
G |
CCL2 |
C-C motif chemokine ligand 2 |
disease_progression |
ISO |
associated with colorectal cancer |
RGD |
PMID:27058904 |
RGD:14995463 |
NCBI chr 9:39,008,187...39,009,932
|
|
G |
CCL5 |
C-C motif chemokine ligand 5 |
treatment |
ISO |
associated with Animal Mammary Neoplasms; |
RGD |
PMID:15692764 |
RGD:14995455 |
NCBI chr 9:37,817,409...37,823,852
Ensembl chr 9:37,817,305...37,823,852
|
|
G |
CCND2 |
cyclin D2 |
|
ISO |
associated with colorectal cancer;protein:increased expression:colorectum |
RGD |
PMID:19508551 |
RGD:151665111 |
NCBI chr27:40,563,306...40,593,362
Ensembl chr27:40,564,921...40,594,255
|
|
G |
CCNG1 |
cyclin G1 |
treatment |
ISO |
human cells in mouse model |
RGD |
PMID:10910035 |
RGD:151356987 |
NCBI chr 4:47,800,697...47,808,259
Ensembl chr 4:47,801,575...47,808,211
|
|
G |
CD44 |
CD44 molecule |
|
ISO |
associated with Breast Neoplasm;protein:increased expression:liver |
RGD |
PMID:17991717 |
RGD:2289349 |
NCBI chr18:32,735,493...32,826,483
Ensembl chr18:32,737,907...32,827,107
|
|
G |
CHD4 |
chromodomain helicase DNA binding protein 4 |
ameliorates |
ISO |
associated with human colon adenocarcinoma cells in a mouse model |
RGD |
PMID:28486105 |
RGD:153323299 |
NCBI chr27:38,411,009...38,440,367
Ensembl chr27:38,411,075...38,439,958
|
|
G |
CXCL10 |
C-X-C motif chemokine ligand 10 |
treatment |
ISO |
associated with colon carcinoma; |
RGD |
PMID:30381616 |
RGD:27095891 |
NCBI chr32:598,406...599,925
Ensembl chr32:597,987...599,979
|
|
G |
CXCL12 |
C-X-C motif chemokine ligand 12 |
ameliorates |
ISO |
associated with colorectal cancer; human cells in mouse model |
RGD |
PMID:30789971 |
RGD:151893289 |
NCBI chr28:2,895,916...2,903,543
|
|
G |
CXCL8 |
C-X-C motif chemokine ligand 8 |
|
ISO |
associated with colorectal cancer; human colon adenocarcinoma cells in a mouse model |
RGD |
PMID:29679563 |
RGD:26884358 |
NCBI chr13:62,435,035...62,438,354
Ensembl chr13:62,434,422...62,438,354
|
|
G |
CXCR4 |
C-X-C motif chemokine receptor 4 |
ameliorates |
ISO |
associated with colorectal cancer; human cells in mouse model human cells in mouse model; associated with colorectal cancer |
RGD |
PMID:29436696 PMID:30789971 |
RGD:151893289 RGD:152023643 |
NCBI chr19:38,874,650...38,877,740
Ensembl chr19:38,874,145...38,877,740
|
|
G |
DAXX |
death domain associated protein |
exacerbates |
ISO |
associated with neuroendocrine tumor;DNA:mutations:CDS:multiple (human) associated with pancreatic endocrine carcinoma;DNA:mutations:CDS:multiple (human) associated with colon cancer; mRNA:decreased expression:liver (human) |
RGD |
PMID:30339629 PMID:30342802 PMID:31942198 |
RGD:152025194 RGD:152025199 RGD:152025203 |
NCBI chr12:2,755,960...2,760,687
Ensembl chr12:2,755,960...2,761,340
|
|
G |
DDR1 |
discoidin domain receptor tyrosine kinase 1 |
treatment |
ISO |
mRNA:increased expression:liver (mouse) human cells in mouse model; nilotinib |
RGD |
PMID:29438985 PMID:30666650 PMID:33110221 |
RGD:151347537 RGD:151347685 RGD:151347840 |
NCBI chr12:653,800...671,190
Ensembl chr12:653,807...670,543
|
|
G |
DDR2 |
discoidin domain receptor tyrosine kinase 2 |
ameliorates |
ISO |
associated with colon carcinoma associated with melanoma; |
RGD |
PMID:21701781 PMID:22071959 |
RGD:150429701 RGD:150429713 |
NCBI chr38:20,002,984...20,152,930
Ensembl chr38:20,008,057...20,152,275
|
|
G |
DOCK6 |
dedicator of cytokinesis 6 |
ameliorates |
ISO |
associated with stomach cancer; |
RGD |
PMID:29587866 |
RGD:155791564 |
NCBI chr20:50,029,354...50,066,829
Ensembl chr20:50,029,369...50,066,829
|
|
G |
FBXW7 |
F-box and WD repeat domain containing 7 |
disease_progression |
ISO |
associated with colorectal cancer; |
RGD |
PMID:28846828 |
RGD:21408566 |
NCBI chr15:50,187,579...50,417,188
Ensembl chr15:50,189,240...50,417,195
|
|
G |
FGFR1 |
fibroblast growth factor receptor 1 |
|
ISO |
associated with colorectal cancer;mRNA:increased expression:colorectal mucosa: |
RGD |
PMID:19082464 |
RGD:25330357 |
NCBI chr16:27,029,902...27,080,514
Ensembl chr16:27,031,588...27,078,261
|
|
G |
FOSL2 |
FOS like 2, AP-1 transcription factor subunit |
|
ISO |
human cells in mouse model |
RGD |
PMID:30114390 |
RGD:153344554 |
NCBI chr17:22,340,469...22,364,994
Ensembl chr17:22,341,322...22,361,772
|
|
G |
GPC3 |
glypican 3 |
|
ISO |
protein:increased expression:blood serum (human) |
RGD |
PMID:28801286 |
RGD:243065135 |
NCBI chr X:104,313,426...104,751,215
Ensembl chr X:104,313,591...104,751,756
|
|
G |
HMBS |
hydroxymethylbilane synthase |
|
ISO |
associated with colon adenocarcinoma;protein:decreased activity:liver(rat) |
RGD |
PMID:1386052 |
RGD:25440496 |
NCBI chr 5:14,767,306...14,775,205
Ensembl chr 5:14,767,666...14,775,082
|
|
G |
IL2 |
interleukin 2 |
treatment |
ISO |
associated with colon carcinoma associated with Colorectal Neoplasms, Carcinoma, Hepatocellular; |
RGD |
PMID:9354462 PMID:11591892 |
RGD:14928215 RGD:8663446 |
NCBI chr19:17,750,780...17,756,394
Ensembl chr19:17,750,780...17,756,394
|
|
G |
IQSEC1 |
IQ motif and Sec7 domain ArfGEF 1 |
|
ISO |
human cells in mouse model |
RGD |
PMID:22662237 |
RGD:153344589 |
NCBI chr20:3,241,058...3,403,394
Ensembl chr20:3,241,052...3,522,859
|
|
G |
MAP2K7 |
mitogen-activated protein kinase kinase 7 |
|
ISO |
associated with colon cancer;protein:increased expression:colon (human) |
RGD |
PMID:24533778 |
RGD:155259116 |
NCBI chr20:52,594,450...52,604,236
Ensembl chr20:52,594,536...52,602,150
|
|
G |
MIR148B |
microRNA mir-148b |
exacerbates |
ISO |
associated with stomach cancer; |
RGD |
PMID:29587866 |
RGD:155791564 |
NCBI chr27:975,146...975,206
Ensembl chr27:975,131...975,220
|
|
G |
MIR155 |
microRNA mir-155 |
|
ISO |
|
RGD |
PMID:26885061 |
RGD:21079444 |
NCBI chr31:21,078,768...21,078,828
Ensembl chr31:21,078,758...21,078,833
|
|
G |
MIR200B |
microRNA mir-200b |
|
ISO |
associated with colorectal cancer;RNA:increased expression:liver: |
RGD |
PMID:28617555 |
RGD:14928321 |
NCBI chr 5:56,368,400...56,368,479
Ensembl chr 5:56,368,400...56,368,479
|
|
G |
MIR200C |
microRNA mir-200c |
|
ISO |
associated with colorectal cancer;RNA:increased expression:liver: |
RGD |
PMID:28617555 |
RGD:14928321 |
NCBI chr27:38,082,097...38,082,159
Ensembl chr27:38,082,091...38,082,169
|
|
G |
MIR223 |
microRNA mir-223 |
disease_progression |
ISO |
associated with colorectal cancer; |
RGD |
PMID:28846828 |
RGD:21408566 |
NCBI chr X:50,838,131...50,838,233
Ensembl chr X:50,838,131...50,838,233
|
|
G |
MIR494 |
microRNA mir-494 |
exacerbates |
ISO |
associated with pancreatic ductal adenocarcinoma; |
RGD |
PMID:24859161 |
RGD:156430321 |
NCBI chr 8:69,261,385...69,261,465
Ensembl chr 8:69,261,385...69,261,465
|
|
G |
MPL |
MPL proto-oncogene, thrombopoietin receptor |
exacerbates severity |
ISO |
associated with pancreatic cancer; protein:increased expression:liver, pancreas (human) associated with pancreatic ductal adenocarcinoma; human cells in mouse model associated with colorectal carcinoma;protein:increased expression:colorectum (human) |
RGD |
PMID:23747337 PMID:30770989 |
RGD:126925751 RGD:126925752 |
NCBI chr15:16,815,102...16,825,321
Ensembl chr15:16,815,294...16,825,350
|
|
G |
NRAS |
NRAS proto-oncogene, GTPase |
susceptibility |
ISO |
associated with colorectal cancer;DNA:mutations:exons (human) human gene in a mouse model;DNA:missense mutations:cds:p.G12V, p.Q61K (human) associated with melanoma;DNA:mutations: exons (human) |
RGD |
PMID:26799184 PMID:28011498 PMID:28787433 |
RGD:14696774 RGD:14696791 RGD:14696792 |
NCBI chr17:52,411,733...52,418,788
Ensembl chr17:52,411,733...52,418,788
|
|
G |
PTPRB |
protein tyrosine phosphatase receptor type B |
treatment |
ISO |
mouse tumor cells in mouse recipient |
RGD |
PMID:31348125 |
RGD:151660353 |
NCBI chr10:12,267,891...12,384,522
Ensembl chr10:12,241,716...12,384,435
|
|
G |
RICTOR |
RPTOR independent companion of MTOR complex 2 |
disease_progression |
ISO |
mRNA:increased expression:liver (human) |
RGD |
PMID:30404068 |
RGD:152995463 |
NCBI chr 4:69,903,393...70,013,168
Ensembl chr 4:69,936,379...70,010,566
|
|
G |
RNF43 |
ring finger protein 43 |
|
ISO |
associated with colorectal adenocarcinoma;mRNA:increased expression:liver (human) |
RGD |
PMID:28789449 |
RGD:151361221 |
NCBI chr 9:32,996,668...33,061,781
Ensembl chr 9:32,997,937...33,060,313
|
|
G |
SLC3A2 |
solute carrier family 3 member 2 |
severity |
ISO |
associated with colon adenocarcinoma |
RGD |
PMID:11745822 |
RGD:151361130 |
NCBI chr18:53,810,468...53,819,021
Ensembl chr18:53,810,398...53,819,021
|
|
G |
SLC7A5 |
solute carrier family 7 member 5 |
severity |
ISO |
associated with colon adenocarcinoma associated with colon cancer |
RGD |
PMID:11718450 PMID:11745822 |
RGD:151361129 RGD:151361130 |
NCBI chr 5:65,313,105...65,343,858
Ensembl chr 5:65,313,105...65,343,858
|
|
G |
SMAD4 |
SMAD family member 4 |
treatment |
ISO |
associated with colorectal carcinoma;protein:decreased expression:colorectum: associated with colorectal carcinoma; DNA:mutations: : |
RGD |
PMID:17390050 PMID:29551247 |
RGD:18937000 RGD:21066338 |
NCBI chr 1:23,875,989...23,930,027
Ensembl chr 1:23,882,139...23,969,405
|
|
G |
SOX30 |
SRY-box transcription factor 30 |
ameliorates |
ISO |
|
RGD |
PMID:29739711 |
RGD:151660333 |
NCBI chr 4:52,587,163...52,615,945
Ensembl chr 4:52,587,355...52,615,945
|
|
G |
SRC |
SRC proto-oncogene, non-receptor tyrosine kinase |
disease_progression |
ISO |
associated with colon cancer;protein:increased activity:colon |
RGD |
PMID:7678609 |
RGD:150521542 |
NCBI chr24:25,982,499...26,019,748
Ensembl chr24:25,999,048...26,018,077
|
|
G |
VEGFA |
vascular endothelial growth factor A |
|
ISO |
associated with colorectal carcinoma;mRNA,protein:increased expression:liver: |
RGD |
PMID:22156924 |
RGD:15014782 |
NCBI chr12:12,209,032...12,224,978
Ensembl chr12:12,208,231...12,224,965
|
|